Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomised, DB, Plcb Controlled, Multicentre, Multinational Phase II/III Study to Assess the Efficacy and Safety of Three Different Dose Regimens of Oralgen Grass Pollen in Patients With Grass Pollen Related Allergic Rhinoconjunctivitis

NCT00567346 is registered in ClinicalTrials.gov with Artu Biologicals as lead sponsor.

NCT NCT00567346
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00567346 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomised, DB, Plcb Controlled, Multicentre, Multinational Phase II/III Study to Assess the Efficacy and Safety of Three Different Dose Regimens of Oralgen Grass Pollen in Patients With Grass Pollen Related Allergic Rhinoconjunctivitis
Lead sponsor
Artu Biologicals
Phase
Phase 2/3
Overall status
Completed
Start date
December 31, 2006
Completion date
March 31, 2008
Enrollment
605 (actual)
Sites
40

Conditions

As the registry lists them; a condition with its own page is linked.

allergic rhinoconjunctivitis